Hou, Y., Kohanbash, G., Okada, K., et al. (2015) Novel and Shared Neoantigen for Glioma T Cell Therapy Derived from Histone 3 Variant H3.3 K27M Mutation. Journal for ImmunoTherapy of Cancer, 3, P445.
http://dx.doi.org/10.1186/2051-1426-3-S2-P445

has been cited by the following article:

• TITLE: Maximizing Function and Quality of Life of Patients with Glioblastoma after Surgical Resection: A Review of Current Literature

  AUTHORS: Matthew Smith-Cohn, Zhijian Chen, David Peereboom, Glen Stevens

  KEYWORDS: Palliative, Glioblastoma, Steroids, Seizure, Rehabilitation, Myopathy

  JOURNAL NAME: Journal of Cancer Therapy, Vol.7 No.12, November 4, 2016

  ABSTRACT: After surgical resection, patients with glioblastoma require many aspects of care to maximize function and quality of life. Patients face a multitude of hurdles that require the expertise of a variety of specialists. Here we will review the current literature on management of glioblastoma patients after surgical resection.